Perceptive Advisors LLC Aldeyra Therapeutics, Inc. Transaction History
Perceptive Advisors LLC
- $2.39 Billion
- Q1 2025
A detailed history of Perceptive Advisors LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Perceptive Advisors LLC holds 9,275,851 shares of ALDX stock, worth $19.3 Million. This represents 2.23% of its overall portfolio holdings.
Number of Shares
9,275,851
Previous 9,275,851
-0.0%
Holding current value
$19.3 Million
Previous $46.3 Million
15.23%
% of portfolio
2.23%
Previous 1.54%
Shares
7 transactions
Others Institutions Holding ALDX
# of Institutions
139Shares Held
38.5MCall Options Held
620KPut Options Held
435K-
Knoll Capital Management, LLC Miami, FL5.48MShares$11.4 Million21.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.72MShares$7.73 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.62MShares$7.53 Million0.0% of portfolio
-
Ardsley Advisory Partners LP Stamford, CT1.75MShares$3.64 Million2.26% of portfolio
-
Kennedy Capital Management, Inc. St Louis, MO1.23MShares$2.57 Million0.18% of portfolio
About Aldeyra Therapeutics, Inc.
- Ticker ALDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 58,323,100
- Market Cap $121M
- Description
- Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...